Pyxis Oncology Inc
NASDAQ:PYXS
Pyxis Oncology Inc
NASDAQ:PYXS
Price:
1.37
USD
-9.27%
Market Closed
Market Cap:
$85.3m
Cash Flow Statement
Cash Flow Statement
Pyxis Oncology Inc
Pyxis Oncology Inc
Currency: USD
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(50)
|
(53)
|
(64)
|
(76)
|
(71)
|
(88)
|
(101)
|
(121)
|
(109)
|
(99)
|
(94)
|
(74)
|
(58)
|
(59)
|
(57)
|
(77)
|
(95)
|
(96)
|
(97)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
2
|
3
|
3
|
6
|
7
|
11
|
15
|
16
|
17
|
17
|
18
|
17
|
16
|
16
|
13
|
13
|
12
|
12
|
12
|
|
| Other Non-Cash Items |
24
|
26
|
29
|
33
|
13
|
15
|
16
|
26
|
27
|
25
|
24
|
13
|
12
|
10
|
8
|
29
|
28
|
29
|
30
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(4)
|
4
|
7
|
7
|
12
|
2
|
0
|
5
|
(8)
|
(3)
|
(4)
|
(12)
|
(21)
|
(11)
|
(7)
|
(10)
|
8
|
(7)
|
(5)
|
|
| Cash from Operating Activities |
(29)
N/A
|
(22)
+25%
|
(26)
-21%
|
(35)
-34%
|
(44)
-25%
|
(71)
-60%
|
(84)
-19%
|
(89)
-6%
|
(89)
+1%
|
(76)
+14%
|
(73)
+4%
|
(71)
+3%
|
(65)
+9%
|
(57)
+12%
|
(54)
+5%
|
(58)
-8%
|
(59)
-3%
|
(74)
-24%
|
(72)
+2%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(5)
|
(6)
|
(11)
|
(13)
|
(9)
|
(7)
|
(3)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
| Other Items |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(95)
|
(115)
|
(108)
|
(98)
|
(21)
|
(1)
|
(8)
|
8
|
42
|
58
|
69
|
|
| Cash from Investing Activities |
(2)
N/A
|
(1)
+57%
|
(1)
+19%
|
(1)
N/A
|
(1)
+12%
|
(0)
+46%
|
(5)
-1 521%
|
(6)
-41%
|
(106)
-1 551%
|
(128)
-21%
|
(117)
+8%
|
(105)
+10%
|
(24)
+77%
|
(2)
+93%
|
(8)
-389%
|
8
N/A
|
42
+421%
|
58
+36%
|
69
+20%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
152
|
152
|
152
|
304
|
153
|
153
|
153
|
0
|
0
|
6
|
6
|
6
|
64
|
58
|
60
|
60
|
2
|
2
|
0
|
|
| Other |
(0)
|
(1)
|
(2)
|
0
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
152
N/A
|
151
0%
|
149
-1%
|
304
+104%
|
153
-50%
|
153
+0%
|
155
+1%
|
0
-100%
|
0
N/A
|
6
N/A
|
6
-3%
|
6
0%
|
63
+970%
|
57
-9%
|
59
+3%
|
59
+0%
|
2
-97%
|
2
-10%
|
(0)
N/A
|
|
| Change in Cash | ||||||||||||||||||||
| Net Change in Cash |
121
N/A
|
128
+6%
|
122
-5%
|
268
+119%
|
108
-60%
|
82
-24%
|
66
-19%
|
(96)
N/A
|
(194)
-103%
|
(197)
-2%
|
(184)
+7%
|
(170)
+8%
|
(25)
+85%
|
(1)
+97%
|
(3)
-219%
|
10
N/A
|
(15)
N/A
|
(14)
+6%
|
(3)
+78%
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(30)
N/A
|
(22)
+27%
|
(27)
-20%
|
(36)
-34%
|
(45)
-25%
|
(71)
-59%
|
(89)
-25%
|
(96)
-8%
|
(99)
-4%
|
(89)
+11%
|
(81)
+8%
|
(77)
+5%
|
(67)
+13%
|
(57)
+15%
|
(54)
+5%
|
(58)
-8%
|
(59)
-3%
|
(74)
-24%
|
(72)
+2%
|
|
Switch to:
Switch to:
See Also
Discover More
